|
End-of-day quote
Egyptian Exchange
|
||
| - EGP | - |
|
| 27/09 | The Arab Drug Company Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 21/05 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| Market Cap | 326.41Cr 6.23Cr 5.57Cr 5.2Cr 4.72Cr 8.89Cr 602.94Cr 8.95Cr 62Cr 24Cr 306.64Cr 23Cr 23Cr 985.76Cr | P/E 2025 |
6.08x | P/E 2026 | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 370.46Cr 7.07Cr 6.32Cr 5.9Cr 5.36Cr 10Cr 684.31Cr 10Cr 71Cr 28Cr 348.02Cr 27Cr 26Cr 1.12TCr | EV / Sales 2025 |
1.47x | EV / Sales 2026 | 2.43x |
| Free-Float |
18.09% | Yield 2025 |
4.14% | Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 30/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.70% | +2.73% | +40.91% | +110.31% | 1,06000Cr | |
| +1.44% | -2.38% | +36.83% | +63.95% | 62TCr | |
| +1.75% | +3.73% | +16.55% | +83.05% | 48TCr | |
| +0.60% | -1.73% | +62.98% | +37.46% | 35TCr | |
| +2.92% | +3.12% | +24.78% | +45.10% | 35TCr | |
| +2.42% | +0.05% | +14.13% | +35.80% | 27TCr | |
| +1.86% | -0.81% | -4.69% | +12.20% | 25TCr | |
| +2.60% | -2.00% | +39.77% | +54.44% | 22TCr | |
| +1.82% | -1.48% | +25.75% | +96.48% | 18TCr | |
| Average | +1.46% | -0.48% | +28.56% | +59.87% | 42.09TCr | |
| Weighted average by Cap. | +0.81% | +0.04% | +32.00% | +70.72% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 111.82Cr 2.14Cr 1.91Cr 1.78Cr 1.62Cr 3.04Cr 206.55Cr 3.07Cr 21Cr 8.36Cr 105.04Cr 8.02Cr 7.84Cr 337.69Cr | 137.03Cr 2.62Cr 2.34Cr 2.18Cr 1.98Cr 3.73Cr 253.11Cr 3.76Cr 26Cr 10Cr 128.73Cr 9.82Cr 9.61Cr 413.82Cr |
| Net income | 23Cr 43.51L 38.88L 36.27L 32.94L 62.05L 42Cr 62.51L 4.36Cr 1.7Cr 21Cr 1.63Cr 1.6Cr 69Cr | 26Cr 50.55L 45.16L 42.14L 38.27L 72.08L 49Cr 72.62L 5.06Cr 1.98Cr 25Cr 1.9Cr 1.86Cr 80Cr |
| Net Debt | 43Cr 82.66L 73.86L 68.91L 62.59L 1.18Cr 80Cr 1.19Cr 8.28Cr 3.23Cr 41Cr 3.1Cr 3.04Cr 130.73Cr | 44Cr 84.12L 75.16L 70.12L 63.69L 1.2Cr 81Cr 1.21Cr 8.43Cr 3.29Cr 41Cr 3.16Cr 3.09Cr 133.04Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
